217 papers
Understanding the human mind and treating mental health conditions requires a deep blend of biological insight and behavioral science. This category explores the cutting-edge research shaping how we diagnose and treat psychiatric disorders, from depression and anxiety to complex neurological conditions. Here, you will find the latest discoveries that bridge the gap between clinical observation and molecular mechanisms, offering fresh perspectives on patient care and therapeutic innovation.
Gist.Science brings these vital studies directly to you by monitoring medRxiv, the leading preprint server for health sciences. As soon as new manuscripts appear in this field, our team processes them to provide both accessible plain-language summaries and detailed technical overviews. This ensures that complex findings are understandable for everyone, from curious readers to busy professionals who need quick, accurate insights without wading through dense academic prose.
Below are the most recent psychiatry and clinical psychology preprints, curated and summarized to keep you informed on the evolving landscape of mental health research.
This study demonstrates that conventional population-based analyses overestimate the direct causal impact of ADHD genetic liability on adverse health and behavioral outcomes, revealing that much of this burden actually stems from shared familial and environmental factors rather than the individual's condition itself.
By applying machine learning to a large global dataset, this study identifies three distinct cerebellar imaging subtypes in schizophrenia with unique spatiotemporal trajectories, biological mechanisms, and clinical outcomes, offering a foundation for future clinical stratification and targeted interventions.
This study demonstrates that a GABAergic neurotransmitter-based polygenic score is significantly associated with improved SSRI treatment response in patients with major depressive disorder, suggesting its potential utility in pharmacogenomic research while highlighting the need for further validation before clinical application.
Using data from the UK Millennium Cohort Study, this research demonstrates that young adults at the intersection of sexual minority status, female sex, childhood poverty, and ethnic minority backgrounds face the most severe mental health inequalities, revealing that accounting for measurement differences and intersectional factors uncovers disparities that would otherwise remain undetected.
By integrating within-case genome-wide association studies with cross-tissue transcriptomic analyses in a large ASD cohort, this study identifies common variant-mediated molecular mechanisms underlying phenotypic heterogeneity and proposes candidate drugs for phenotypically stratified treatment.
This longitudinal study found no significant differences in intestinal permeability or immune activation markers between individuals with early-stage schizophrenia spectrum disorders and healthy controls, suggesting that variations in these biomarkers are more strongly influenced by metabolic factors like BMI than by the diagnosis or symptom severity of the disorder.
This study reveals that early gray matter volume changes in first-episode schizophrenia-spectrum psychosis are not uniform but consist of two contrasting, clinically distinct patterns: a progressive loss in association and default mode regions associated with poorer functioning and severe negative symptoms, and a distinct increase in ventral temporal volume.
This study of 2,187 U.S. youth demonstrates that while a general symptom burden accounts for the majority of variance in pediatric mood and behavioral issues, person-centered analyses can identify distinct transdiagnostic profiles that coexist with this severity, though measurement limitations and model instability suggest these profiles require further refinement before clinical application.
This feasibility cluster randomized controlled trial in Ghana demonstrates that a school-based, lay teacher-delivered psychological intervention (Y-MIND) for moderate to severe depression in older adolescents is highly feasible, acceptable, and shows preliminary clinical benefits, thereby justifying a future fully powered trial to establish its effectiveness and scalability in low-and middle-income countries.
This study of 1,617 adults across 13 countries reveals that while the adverse psychosocial consequences of child maltreatment are largely consistent globally, the prevalence and perceived social acceptability of such maltreatment vary significantly across cultures, highlighting the need for culturally sensitive interventions.